Related Posts
ASCO: Adding Atezolizumab to Cabozantinib No Benefit in Advanced Renal Cancer
FRIDAY, June 9, 2023 (HealthDay News) -- For patients with locally advanced or...
Los investigadores podrían estar cerca de una cura para la diabetes tipo 1
VIERNES, 25 de febrero de 2022 (HealthDay News) -- La ciencia quizá se esté...
Publication of ARRIVE Trial Linked to Increase in 39-Week Induction
FRIDAY, Aug. 11, 2023 (HealthDay News) -- An increase in 39-week induction rates...
U.K. Is First Country to Approve Moderna’s Omicron-Targeted COVID Vaccine
MONDAY, Aug. 15, 2022 (HealthDay News) -- A COVID-19 booster that's targeted to...